In vitro evaluation of Sporothrix brasiliensis biotherapic: complete results

Gleyce Moreno Barbosa, Amanda Ribeiro Ricardo Brito, Paloma Barbosa da Silva Moura, Camily Da Silva Faria, Lais Cavalcanti dos Santos Velasco de Souza, Leandro Machado Rocha, Andrea Regina de Souza Baptista
{"title":"In vitro evaluation of Sporothrix brasiliensis biotherapic: complete results","authors":"Gleyce Moreno Barbosa, Amanda Ribeiro Ricardo Brito, Paloma Barbosa da Silva Moura, Camily Da Silva Faria, Lais Cavalcanti dos Santos Velasco de Souza, Leandro Machado Rocha, Andrea Regina de Souza Baptista","doi":"10.51910/ijhdr.v22i2.1356","DOIUrl":null,"url":null,"abstract":"Background: Sporothrix brasiliensis is a fungus that affects animals, mainly felines, and humans. The infection can present as subcutaneous or disseminated form in the organism. Rio de Janeiro, Brazil, is a state with high prevalence of cases in felines. Currently, the standard treatment is realized during a long period and using itraconazole, that causes important adverse effects. Objective: The aim of this research was to evaluate in vitro effect of Sporothrix brasiliensis biotherapic in the fungus used to prepare this medicine, also considering the association to itraconazole. Methodology: Yeast cells of S. brasiliensis (ATCC MYA 4823) were cultured in Brain Heart Infusion (BHI) during 3 to 5 days. The biotherapic 30 DH was prepared according to Brazilian Homeopathic Pharmacopoeia, using 5 x 107 yeasts/mL. Two biotherapics were prepared: using inactivated fungus by autoclave (Sb1) and viable yeasts (Sb2). Both biotherapics were evaluated individually and associated to itraconazole. The control groups were: water, diluted water, water 30 DH, and dimethylsulfoxide (vehicle to dissolve itraconazole), and itraconazole. The minimum inhibitory concentration (MIC) experiments were carried out, considering the CLSI (Clinical & Laboratory Standards Institute) guidelines. Results:  The treatments using only biotherapic did not reduced the yeast viability, as observed in the controls. However, the higher concentrations of itraconazole and of this drug associated with biotherapic reduced the viability of S. brasiliensis. Then, the observed effect was attributed to itraconazole. Conclusion: As expected, it was not detected the effect of both biotherapic in the viability of microorganism itself, due to the integrality aspects of homeopathy, because the homeopathic medicine emphasizes the whole organism’s response to the symptoms presented. Then, the next step is to evaluate the biotherapic in an in vivo model, that will be a complete organism representing the host to this infection.","PeriodicalId":106057,"journal":{"name":"International Journal of High Dilution Research - ISSN 1982-6206","volume":"142 3","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-12-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of High Dilution Research - ISSN 1982-6206","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.51910/ijhdr.v22i2.1356","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Sporothrix brasiliensis is a fungus that affects animals, mainly felines, and humans. The infection can present as subcutaneous or disseminated form in the organism. Rio de Janeiro, Brazil, is a state with high prevalence of cases in felines. Currently, the standard treatment is realized during a long period and using itraconazole, that causes important adverse effects. Objective: The aim of this research was to evaluate in vitro effect of Sporothrix brasiliensis biotherapic in the fungus used to prepare this medicine, also considering the association to itraconazole. Methodology: Yeast cells of S. brasiliensis (ATCC MYA 4823) were cultured in Brain Heart Infusion (BHI) during 3 to 5 days. The biotherapic 30 DH was prepared according to Brazilian Homeopathic Pharmacopoeia, using 5 x 107 yeasts/mL. Two biotherapics were prepared: using inactivated fungus by autoclave (Sb1) and viable yeasts (Sb2). Both biotherapics were evaluated individually and associated to itraconazole. The control groups were: water, diluted water, water 30 DH, and dimethylsulfoxide (vehicle to dissolve itraconazole), and itraconazole. The minimum inhibitory concentration (MIC) experiments were carried out, considering the CLSI (Clinical & Laboratory Standards Institute) guidelines. Results:  The treatments using only biotherapic did not reduced the yeast viability, as observed in the controls. However, the higher concentrations of itraconazole and of this drug associated with biotherapic reduced the viability of S. brasiliensis. Then, the observed effect was attributed to itraconazole. Conclusion: As expected, it was not detected the effect of both biotherapic in the viability of microorganism itself, due to the integrality aspects of homeopathy, because the homeopathic medicine emphasizes the whole organism’s response to the symptoms presented. Then, the next step is to evaluate the biotherapic in an in vivo model, that will be a complete organism representing the host to this infection.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
巴西孢子虫生物疗法的体外评估:完整结果
背景:巴西孢子丝菌是一种真菌,可影响动物(主要是猫科动物)和人类。这种真菌感染可表现为皮下感染或播散感染。巴西里约热内卢是猫科动物病例高发的一个州。目前,标准治疗是通过长期使用伊曲康唑来实现的,但伊曲康唑会导致严重的不良反应。研究目的本研究的目的是评估用于制备这种药物的巴西孢子菌生物治疗剂的体外效果,同时考虑与伊曲康唑的关联性。研究方法:将巴西孢子菌(ATCC MYA 4823)的酵母细胞在脑心输液(BHI)中培养 3 至 5 天。根据巴西顺势疗法药典,使用 5 x 107 个酵母/毫升配制生物治疗剂 30 DH。制备了两种生物疗法:使用高压灭活真菌(Sb1)和活酵母菌(Sb2)。对两种生物疗法进行了单独评估,并将其与伊曲康唑结合使用。对照组包括:水、稀释水、30 DH 水、二甲基亚砜(溶解伊曲康唑的载体)和伊曲康唑。根据 CLSI(临床与实验室标准研究所)指南,进行了最低抑菌浓度(MIC)实验。实验结果 与对照组相比,仅使用生物治疗剂的处理并未降低酵母菌的活力。然而,伊曲康唑浓度较高时,以及该药物与生物治疗剂联合使用时,巴西酵母菌的活力会降低。因此,观察到的效果归因于伊曲康唑。结论正如预期的那样,由于顺势疗法的整体性,两种生物治疗剂都没有对微生物本身的活力产生影响,因为顺势疗法强调整个机体对所出现症状的反应。下一步是在体内模型中对生物疗法进行评估,该模型将是一个完整的生物体,代表感染的宿主。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Homoeopathic treatment for chronic cough – a multicentric, prospective, exploratory trial Efficacy of Homeopathic Higher Dilutions in management of Sleep Disorders: A Review Antiadipogenic activity of homoeopathic preparation of Chelidonium Majus employing3T3-L1 cell line as a model. “Exploring the potential of Homoeopathy: A detailed examination of Systematic Review and Meta- analysis procedure- weighing the Pros and Cons” The Crucial Role of Prognostic Factor Research Models in Guiding Homeopathic Prescriptions: An Evidence Based Medicine perspective.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1